US approves Ascendis Pharma’s therapy for hormone disorders
Ascendis Pharma said the US Food and Drug Administration approved its therapy to treat adult patients with a hormone disorder. This sent the drugmaker’s shares up more than 10%.
BELIEBTE BEITRÄGE
UK sets new climate target for 2035
November 13, 2024
Children go back to school after Valencia floods
November 13, 2024
Researchers document huge decline in African elephants
November 13, 2024
Mission: Impossible 8 title revealed
November 13, 2024
LIVEÜBERTRAGUNG